Access to innovative drugs and the National Reimbursement Drug List in China: Changing dynamics and future trends in pricing and reimbursement-Reference-Cited by-同舟云学术

Access to innovative drugs and the National Reimbursement Drug List in China: Changing dynamics and future trends in pricing and reimbursement

Published:2023-06-13 Issue:1 Volume:11 Page:
ISSN:2001-6689
Container-title:Journal of Market Access & Health Policy
language:en
Short-container-title:Journal of Market Access & Health Policy

Author:

Macabeo Bérengère¹²,Wilson Liam³,Xuan Jianwei⁴,Guo Ruichen⁵,Atanasov Petar⁶,Zheng Linda⁷,François Clement¹⁸,Laramée Philippe¹²

Affiliation:

1. Aix-Marseille Université, Marseille, France

2. Pierre Fabre Group, Paris, France

3. Health Economics and Market Access, Amaris Consulting, Shanghai, China

4. Health Economic Research Institute, Sun Yat-Sen University, Guangzhou, China

5. Institute of Clinical Pharmacology, Qilu Hospital of Shandong University, Jinan, China

6. Health Economics and Market Access, Amaris Consulting, Barcelona, Spain

7. Pierre Fabre Group, Shanghai, China

8. Putnam Associates, Paris, France

Funder

Pierre Fabre Group

Publisher

MDPI AG

Subject

Health Informatics,Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/20016689.2023.2218633

Reference33 articles.

1. The development and reform of public health in China from 1949 to 2019

2. The effect of medical insurance on catastrophic health expenditure: evidence from China

3. National Health Commission. 2020年我国卫生健康事业发展统计公报 [2020 Statistical Bulletin on the Development of my country's Health Care]. http://www.nhc.gov.cn/guihuaxxs/s10743/202107/af8a9c98453c4d9593e07895ae0493c8.shtml. Chinese. 2021 Accessed July 15 2021.

4. National Health Commission. 2015年我国卫生和计划生育事业发展统计公报 [2015 Statistical Bulletin on the Development of Health and Family Planning in my country]. http://www.nhc.gov.cn/guihuaxxs/s10748/201607/da7575d64fa04670b5f375c87/b6229b0.shtml. Chinese. 2016 Accessed July 15 2021.

5. National Health Commission. 2016年我国卫生和计划生育事业发展统计公报 [2016 Statistical Bulletin on the Development of Health and Family Planning in my country]. http://www.nhc.gov.cn/guihuaxxs/s10748/201708/d82fa7141696407abb4ef764f3edf095.shtml. Chinese. 2017. Accessed July 15 2021.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship between Prices of Fixed-dose and Free-equivalent Combination: A Survey of Medicines in China's National Reimbursement Drug List;2024-08-29

2. Health Technology Assessment in China’s Health Care Sector: Development and Applications;Health Systems & Reform;2023-12-31

3. Medicinal product early access programs: experience of the BRICS group, European Union, and United States of America;Медицинская этика;2023-11

4. Topic and Trend Analysis of Weibo Discussions About COVID-19 Medications Before and After China’s Exit from the Zero-COVID Policy: Retrospective Infoveillance Study;Journal of Medical Internet Research;2023-10-27